Literature DB >> 10535886

Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat.

V Shah1, M Toruner, F Haddad, G Cadelina, A Papapetropoulos, K Choo, W C Sessa, R J Groszmann.   

Abstract

BACKGROUND & AIMS: A reduction in nitric oxide (NO) has been implicated as a cause of intrahepatic vasoconstriction in cirrhosis, but the regulatory mechanisms remain undefined. The aim of this study was to examine a contributory role for caveolin-1, a putative negative regulator of endothelial NO synthase, in mediating deficient intrahepatic NO production in the intact cirrhotic liver.
METHODS: Cirrhosis was induced by carbon tetrachloride inhalation. Flow regulation of NO production and perfusion pressure was examined in the perfused rat liver. Protein expression of endothelial NO synthase (eNOS), caveolin, and calmodulin was examined by Western blotting and immunohistochemistry. NOS activity and NO production were assessed by citrulline generation and chemiluminescence, respectively. Protein-protein interactions were examined using whole tissue protein immunoprecipitation.
RESULTS: In response to incremental increases in flow, cirrhotic animals produced significantly less NO(x) than control animals. NOS activity was significantly reduced in liver tissue from cirrhotic animals compared with control animals in the presence of similar eNOS protein levels. Deficient eNOS activity was associated with a severalfold increase in binding of eNOS with caveolin. Protein levels of caveolin-1 were markedly increased in the cirrhotic liver.
CONCLUSIONS: These studies provide evidence that enhanced expression and interaction of caveolin with eNOS contribute to impaired NO production, reduced NOS activity, and vasoconstriction in the intact cirrhotic liver.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10535886     DOI: 10.1016/s0016-5085(99)70408-7

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  70 in total

Review 1.  Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension.

Authors:  H Reynaert; M G Thompson; T Thomas; A Geerts
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

2.  Physiopathology of splanchnic vasodilation in portal hypertension.

Authors:  María Martell; Mar Coll; Nahia Ezkurdia; Imma Raurell; Joan Genescà
Journal:  World J Hepatol       Date:  2010-06-27

3.  NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension.

Authors:  S Fiorucci; E Antonelli; O Morelli; A Mencarelli; A Casini; T Mello; B Palazzetti; D Tallet; P del Soldato; A Morelli
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

Review 4.  Pathophysiology of portal hypertension and its clinical links.

Authors:  Yeon Seok Seo; Vijay H Shah
Journal:  J Clin Exp Hepatol       Date:  2011-11-09

5.  sPECAM-1 and sVCAM-1: Role in Pathogenesis and Diagnosis of Chronic Hepatitis C and Association with Response to Antiviral Therapy.

Authors:  Michal Kukla; Krystyna Zwirska-Korczala; Andrzej Gabriel; Ewa Janczewska-Kazek; Agnieszka Berdowska; Andrzej Wiczkowski; Barbara Rybus-Kalinowska; Mariusz Kalinowski; Adam Ziolkowski; Elzbieta Wozniak-Grygiel; Marek Waluga; Blazej Nowak
Journal:  Therap Adv Gastroenterol       Date:  2009-03       Impact factor: 4.409

Review 6.  Portopulmonary hypertension.

Authors:  Michael Halank; Ralf Ewert; Hans-Juergen Seyfarth; Gert Hoeffken
Journal:  J Gastroenterol       Date:  2006-09       Impact factor: 7.527

Review 7.  Invasive and non-invasive techniques for detecting portal hypertension and predicting variceal bleeding in cirrhosis: a review.

Authors:  Enrico Maria Zardi; Francesco Maria Di Matteo; Claudio Maurizio Pacella; Arun J Sanyal
Journal:  Ann Med       Date:  2013-12-16       Impact factor: 4.709

8.  In vivo gene transfer of endothelial nitric oxide synthase decreases portal pressure in anaesthetised carbon tetrachloride cirrhotic rats.

Authors:  M Van de Casteele; A Omasta; S Janssens; T Roskams; V Desmet; F Nevens; J Fevery
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

9.  Incomplete Differentiation of Engrafted Bone Marrow Endothelial Progenitor Cells Initiates Hepatic Fibrosis in the Rat.

Authors:  Ana C Maretti-Mira; Xiangdong Wang; Lei Wang; Laurie D DeLeve
Journal:  Hepatology       Date:  2019-02-07       Impact factor: 17.425

10.  The role of nitric oxide in the expression of renal aquaporin 2 in a cirrhotic rat model: does an AVP-independent mechanism exist for the regulation of AQP2 expression?

Authors:  Dae Won Jun; Jin Hee Park; Yoo Sin Park; Ju-Seop Kang; Eun Kyung Kim; Kyung Tae Kim; Byoung Kwan Son; Seong Hwan Kim; Yun Ju Jo; Young Sook Park
Journal:  Dig Dis Sci       Date:  2009-06-11       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.